Myocardial dysfunction in septic shock

Critical Care Clinics

Volumn 16, Issue 2, 2000, Pages 251-287

  Kumar, Anand ^a   Haery, Cameron ^b   Parrillo, Joseph E ^b  

^a Section of Critical Care Medicine   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYPERTENSIVE FACTOR; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

DEPRESSION; DIASTOLIC BLOOD PRESSURE; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HEART OUTPUT; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPTIC SHOCK;

EID: 0034112616     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-0704(05)70110-X     Document Type: Article

References (169)

1. A.J. Ahmed J.A. Kruse M.T. Haupt Hemodynamic responses to gram-positive versus gram-negative sepsis in critically ill patients with and without circulatory shock Crit Care Med 19 1991 1520 1525
2. H. Artucio A. Degenio M. Pereyra Left ventricular function during sepsis Crit Care Med 17 1989 323 327
3. G. Azimi J.L. Vincent Ultimate survival from septic shock Resuscitation 14 1986 245 253
4. J.L. Balligand R.A. Kelly P.A. Marsden Control of cardiac muscle cell function by an endogenous nitric oxide signaling system Proc Natl Acad Sci 90 1993 347 351
5. J.L. Balligand L. Kobzik X. Han Nitric oxide-dependent parasympathetic signalling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes J Biological Chem 270 1995 14582 14586
6. J.L. Balligand D. Ungureanu-Longrois W.W. Simmons Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes J Biological Chem 269 1994 27580 27588
7. J.L. Balligand D. Ungureanu R.A. Kelly Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium J Clin Invest 91 1993 2314 2319
8. J. Baumgartner C. Vaney C. Perret An extreme form of hyperdynamic syndrome in septic shock Intensive Care Med 10 1984 245 249
9. C. Benassayag M.C. Christeff M.C. Auclair Early released lipid-soluble cardiodepressant factor and elevated oestrogenic substances in human septic shock Eur J Clin Invest 14 1984 288 294
10. M. Bohm R. Kirchmayr P. Gierschik Increase of myocardial inhibitory G-proteins in catecholamine-refractory septic shock or in septic multiorgan failure Am J Med 98 1995 183 186
11. A.J. Brady P.A. Poole-Wilson S.E. Harding Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia Am J Physiol 263 1992 H1963 H1966
12. A.J. Brady J.B. Warren P.A. Poole-Wilson Nitric oxide attenuates cardiac myocyte contraction Am J Physiol 265 1993 H176 H182
13. E.D. Brand A.M. Lefer Myocardial depressant factor in plasma from cats in irreversible post-oligemic shock Proc Soc Exp Biol Med 122 1966 200 203
14. D. Bryant L. Becker J. Richardson Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha Circulation 97 1998 1375 1381
15. B.S. Cain D.R. Meldrum C.A. Dinarello Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function Crit Care Med 27 1999 1309 1318
16. J.E. Calvin Acute right heart failure: Pathophysiology, recognition, and pharmacological management J Cardiothorac Vasc Anesth 5 1991 507 513
17. J.E. Calvin A.A. Driedger W.J. Sibbald An assessment of myocardial function in human sepsis utilizing ECG gated cardiac scintigraphy Chest 80 1981 579 586
18. J.E. Calvin A.A. Driedger W.J. Sibbald Does the pulmonary wedge pressure predict left ventricular preload in critically ill patients? Crit Care Med 9 1981 437 443
19. J.E. Calvin A.A. Driedger W.J. Sibbald The hemodynamic effect of rapid fluid infusion in critically ill patients Surgery 90 1981 61 76
20. A. Carli M.C. Auclair C. Vernimmen Reversal by calcium of rat heart cell dysfunction induced by human sera in septic shock Circ Shock 6 1979 147 157
21. L.C. Casey R.A. Balk R.C. Bone Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome Ann Intern Med 119 1993 771 778
22. M.K. Chung T.S. Gulick R.E. Rotondo Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: Impairment of signal transduction Circ Res 67 1990 753 763
23. G.H.A. Clowes G.H. Farrington W. Zuschneid Circulating factors in the etiology of pulmonary insufficiency and right heart failure accompanying severe sepsis Ann Surg 171 1970 663 678
24. G.H.A. Clowes M. Vucinic M.G. Weidner Circulatory and metabolic alterations associated with survival or death in peritonitis Ann Surg 163 1966 866
25. F.Q. Cunha J. Assreuy D.W. Moss Differential induction of nitric oxide synthase in various organs of the mouse during endotoxemia: Role of TNF-alpha and IL-1-beta Immunology 81 1994 211 215
26. R.E. Cunnion J.E. Parrillo Myocardial dysfunction in sepsis. Recent insights Chest 95 1989 941 945
27. R.E. Cunnion G.L. Schaer M.M. Parker The coronary circulation in human septic shock Circulation 73 1986 637 644
28. R.L. Danner R.J. Elin J.M. Hosseini Endotoxemia in human septic shock Chest 99 1991 169 175
29. J.E. DeMeules A physiologic explanation for cardiac deterioration in septic shock J Surg Res 36 1984 553 562
30. J.E. DeMeules F.A. Pigula M. Mueller Tumor necrosis factor and cardiac function J Trauma 32 1992 686 692
31. J.F. Dhainaut F. Brunet J.F. Monsallier Bedside evaluation of right ventricular performance using a rapid computerized thermodilution method Crit Care Med 15 1987 148 152
32. J.F. Dhainaut M.F. Huyghebaert J.F. Monsallier Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock Circulation 75 1987 533 541
33. J.F. Dhainaut J.J. Lanore M.F. de Gournay Right ventricular dysfunction in patients with septic shock Intensive Care Med 14 1988 488 491
34. P.W. Eichenholz P.Q. Eichacker W.D. Hoffman Tumor necrosis factor challenges in canines: Patterns of cardiovascular dysfunction Am J Physiol 263 1992 H668 H675
35. R.C. Elkins J.R. McCurdy P.P. Brown Effects of coronary perfusion pressure on myocardial performance during endotoxic shock Surg Gynecol Obstet 137 1973 991 996
36. A.G. Ellrodt M.S. Riedinger A. Kimchi Left ventricular performance in septic shock: Reversible segmental and global abnormalities Am Heart J 110 1985 402 409
37. Endo S, Inada K, Takakuwa T, et al: Nitrite/nitrate and transforming growth factor-beta levels in patients with septic shock. Crit Care Med, in press
38. H.G. Evans M.J. Lewis A.M. Shah Interleukin-1 beta modulates myocardial contraction via dexamethasone sensitive production of nitric oxide Cardiovasc Res 27 1993 1486 1490
39. M.S. Finkel C.V. Oddis T.D. Jacobs Negative inotropic effects of cytokines on the heart mediated by nitric oxide Science 257 1992 387 389
40. E. Fischer M.A. Marano K.J. Van Zee Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock but fails to alter host responses to sublethal endotoxemia J Clin Invest 89 1992 1551 1557
41. C.J. Fisher Jr G.J. Slotner S.M. Opal Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial Crit Care Med 22 1994 12 21
42. C.J. Fisher Jr J.F. Dhainaut S.M. Opal Recombinant human interleukin 1 receptor antagonist in the treatment of patients with the sepsis syndrome: Results from a randomized, double-blind, placebo-controlled trial JAMA 271 1994 1836 1843
43. E. Girardin G.E. Grau J.M. Dayer Plasma tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura N Engl J Med 319 1989 397 400
44. B.P. Giroir J.H. Johnson T. Brown The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia J Clin Invest 90 1992 693 698
45. 2+]i and contractility in isolated adult rabbit ventricular myocytes Am J Physiol 271 1996 H1449 H1455
46. A. Gomez R. Wang H. Unruh Hemofiltration reverses left ventricular dysfunction during sepsis in dogs Anesthesiology 73 1990 671 685
47. R.L. Greenman R.M. Schein M.A. Martin A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis JAMA 266 1991 1097 1102
48. R. Grocott-Mason S. Fort M.J. Lewis Myocardial relaxant of exogenous nitric oxide in isolated ejecting hearts Am J Physiol 266 1994 H1699 H1705
49. A.B.J. Groenveld W. Bronsveld L.G. Thijs Hemodynamic determinants of mortality in human septic shock Surgery 99 1986 140 152
50. A.B.J. Groenveld J.J. Nauta L. Thijs Peripheral vascular resistance in septic shock: Its relation to outcome Intensive Care Med 14 1988 141 147
51. T. Gulick M.K. Chung S.J. Pieper Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte adrenergic responsiveness Proc Natl Acad Sci USA 86 1989 6753 6757
52. C.E. Hack M. Hart R.J. van Schijndel Interleukin-8 in sepsis: Relation to shock and inflammatory mediators Infect Immunol 60 1992 2835 2842
53. 2+ current in adult rabbit atrioventricular nodal cells Circ Res 78 1996 998 1008
54. J.M. Hare J.F. Keaney J.L. Balligand Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs J Clin Invest 95 1995 360 366
55. J.M. Hare E. Loh M.A. Creager Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction Circulation 92 1995 2198 2203
56. S.O. Heard I.E. Toth M.W. Perkins The role of protein kinase C in lipopolysaccharide-induced myocardial depression in guinea pigs Shock 1 1994 419 424
57. D.G. Hesse K.J. Tracey Y. Fong Cytokine appearance in human endotoxemia and primate bacteremia Surg Gynecol Obstet 166 1988 147 153
58. L.B. Hinshaw Myocardial function in endotoxin shock Circ Shock [suppl] 1 1979 43 51
59. L.B. Hinshaw L.T. Archer J.J. Spitzer Effects of coronary hypotension and endotoxin on myocardial performance Am J Physiol 227 1974 1051 1057
60. M.J. Hoffman J.C. Greenfield H.J. Sugerman Unsuspected right ventricular dysfunction in shock and sepsis Ann Surg 198 1983 307 319
61. J.D. Hosenpud S.M. Campbell D.J. Mendelson Interleukin-1-induced myocardial depression in an isolated beating heart preparation J Heart Transplant 8 1989 460 464
62. R.S. Hotchkiss I.E. Karl Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis JAMA 267 1992 1503 1510
63. R.S. Hotchkiss R.S. Rust C.S. Dence Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F] fluoromisonidazole Am J Physiol 261 1991 R965 R972
64. S.M. Jafri S. Lavine B.E. Field Left ventricular diastolic function in sepsis Crit Care Med 18 1991 709 714
65. F. Jardin D. Brun-Ney B. Auvert Sepsis-related cardiogenic shock Crit Care Med 18 1990 1055 1060
66. P. Jha H. Jacobs D. Bose Effects of E. coli sepsis and myocardial depressant factor on interval-force relations in dog ventricle Am J Physiol 264 1993 H1402 H1410
67. S. Kapadia J. Lee G. Torre-Amino Tumor necrosis factor alpha gene expression in adult feline myocardium after endotoxin administration J Clin Invest 96 1995 1042 1052
68. A. Kimchi G.A. Ellrodt D.S. Berman Right ventricular performance in septic shock: A combined radionuclide and hemodynamic study J Am Coll Cardiol 4 1984 945 951
69. +]i and cell contraction in cultured chick ventricular myocytes Circ Res 75 1994 285 295
70. M.M. Krausz A. Perel D. Eimerl Cardiopulmonary effects of volume loading in patients with septic shock Ann Surg 185 1977 429 434
71. A. Kumar R. Brar E. Sun Tumor necrosis factor (TNF) impairs isoproterenol-stimulated cardiac myocyte contractility and cyclic AMP production via a nitric oxide-independent mechanism Crit Care Med 24 1996 A95 Abstract
72. A. Kumar R. Brar P. Wang The role of nitric oxide and cyclic GMP in human septic serum-induced depression of cardiac myocyte contractility Am J Physiol 276 1999 R265 R276
73. A. Kumar E. Choudhury M. Saleem Transforming growth factor (TGF)-beta inhibits human septic serum-induced depression of cardiac myocyte contractility Crit Care Med 27 1999 A124 Abstract
74. A. Kumar R. Kosuri C. Dimou Effects of epinephrine and amrinone on contractility and cyclic AMP generation of TNF-alpha-exposed cardiac myocytes Crit Care Med 27 1999 286 292
75. A. Kumar R. Kosuri B. Ginsburg Myocardial cell contractility is depressed by supernatants of endotoxin stimulated THP-1 cells Crit Care Med 22 1994 A118 Abstract
76. A. Kumar E. Schupp E. Bunnell The cardiovascular response to dobutamine in septic shock Clin Invest Med 17 1994 B18 #107 Abstract
77. A. Kumar V. Thota L. Dee Tumor necrosis factor-alpha and interleukin-1 beta are responsible for depression of in-vitro myocardial cell contractility induced by serum from humans with septic shock J Exp Med 183 1996 949 958
78. H.M. Kwaan M.H. Weil Differences in the mechanism of shock caused by bacterial infections Surg Gynecol Obstet 128 1969 37 45
79. K. Lee H. van der Zee S.W. Dziuban Jr R.D. Goldfarb Left ventricular function during chronic endotoxemia in swine Am J Physiol 254 1988 H324 H330
80. A.M. Lefer Mechanisms of cardiodepression in endotoxin shock Circ Shock 1 suppl 1979 1 8
81. R.C. Levi G. Alloatti C. Penna Guanylate-cyclase-mediated inhibition of cardiac ICa by carbachol and sodium nitroprusside Pflugers Arch 426 1994 419 426
82. W.L. Lovett S.L. Wangensteen T.M. Glenn Presence of a myocardial depressant factor in patients with circulatory shock Surgery 70 1971 223 231
83. L.D. MacLean W.G. Mulligan A.P.H. McLean Responses of left ventricular function in survivors and nonsurvivors of septic shock J Crit Care 4 1999 19 25
84. K.A. Maksad C. Chung-Ja G.H.A. Clowes Myocardial depression in septic shock: Physiologic and metabolic effects of a plasma factor on an isolated heart Circ Shock 1 suppl 1979 35 42
85. A. Marchant M.D. Alegre A. Hakim Clinical and biologic significance of interleukin-10 plasma levels in patients with septic shock J Clin Immunol 15 1995 266 273
86. C. Marie J. Cavaillon M. Losser Elevated levels of circulating transforming growth factor-beta1 in patients with the sepsis syndrome Ann Intern Med 125 1996 520 521
87. C.V. Massey T.R. Kohout S.T. Gaa Molecular and cellular actions of platelet-activating factor in rat heart cells J Clin Invest 88 1991 2106 2116
88. R. McConn J.K. Greineder F. Wasserman Is there a humoral factor that depresses ventricular function in sepsis? Circ Shock 1 1979 9 22
89. E. Mellow M.M. Parker R.E. Cunnion Reversible depression and ventricular dilation demonstrated by two dimensional echocardiography in humans with septic shock Crit Care Med 14 1986 342 Abstract
90. H.R. Michie K.R. Manogue D.R. Spriggs Detection of circulating tumor necrosis factor after endotoxin administration N Engl J Med 318 1988 1481 1486
91. F. Monsalve L. Rucabado A. Salvador Myocardial depression in septic shock caused by meningiococcal infection Crit Care Med 12 1984 1021 1023
92. C. Natanson R.L. Danner R.J. Elin Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock J Clin Invest 83 1989 243 251
93. C. Natanson R.L. Danner M.P. Fink Cardiovascular performance with E. coli challenges in a canine model of human sepsis Am J Physiol 254 1988 H558 H569
94. C. Natanson P.W. Eichenholz R.L. Danner Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock J Exp Med 169 1989 823 832
95. C. Natanson M.P. Fink H.K. Ballantyne Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock J Clin Invest 78 1986 259 270
96. H. Nishijima M.H. Weil H. Shubin Hemodynamic and metabolic studies on shock associated with gram-negative bacteremia Medicine (Baltimore) 52 1973 287 294
97. F. Ognibene M.M. Parker C. Natanson Depressed left ventricular performance to volume infusion in patients with sepsis and septic shock Chest 93 1988 903 910
98. F.P. Ognibene S.A. Rosenberg M. Lotze Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock Chest 94 1988 750 754
99. K. Ohlsson P. Bjork M. Bergenfeldt Interleukin-1 receptor antagonist reduces mortality from endotoxin shock Nature 348 1990 550 552
100. S. Okusawa J.A. Gelfand T. Ikejima Interleukin-1 induces a shock like state in rabbits J Clin Invest 81 1988 1162 1172
101. H. Oral G.W. Dorn D.L. Mann Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian cardiac myocyte J Biological Chem 272 1997 4836 4841
102. M.I. Packman E.C. Rackow Optimum left heart filling pressure during fluid resuscitation of patients with hypovolemic and septic shock Crit Care Med 11 1983 165 169
103. J.L. Parker H.R. Adams Myocardial effects of endotoxin shock: Characterization of an isolated heart muscle model Adv Shock Res 2 1979 163 175
104. J.L. Parker H.R. Adams Contractile dysfunction of atrial myocardium from endotoxin-shocked pigs Am J Physiol 240 1981 H954 H962
105. J.L. Parker H.R. Adams Development of myocardial dysfunction in endotoxin shock Am J Physiol 248 1985 H818 H826
106. M.M. Parker K.E. McCarthy F.P. Ognibene Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans Chest 97 1990 126 131
107. M.M. Parker J.H. Shelhamer S.L. Bacharach Profound but reversible myocardial depression in patients with septic shock Ann Intern Med 100 1984 483 490
108. M.M. Parker A.F. Suffredini C. Natanson Responses of left ventricular function in survivors and non-survivors of septic shock J Crit Care 4 1989 19 25
109. S.M. Parker J.H. Shelhamer C. Natanson Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis Crit Care Med 15 1987 923 929
110. J.E. Parrillo C. Burch J.H. Shelhamer A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance J Clin Invest 76 1985 1539 1553
111. W.J. Paulus P.J. Vantrimpont A.M. Shah Acute effects of nitric oxide on left ventricular relaxation and diastolic distensability in humans. Assessment by bicoronary sodium nitroprusside infusion Circulation 89 1994 2070 2078
112. M.A. Perrella C. Hsieh W. Lee Arrest of endotoxin-induced hypotension by transforming growth factor beta-1 Proc Natl Acad Sci 93 1996 2054 2059
113. M.D. Peyton L.B. Hinshaw L.J. Greenfield The effects of coronary vasodilatation on cardiac performance during endotoxin shock Surg Gynecol Obstet 143 1976 533 538
114. J. Poelaert C. Declerck D. Vogelaers Left ventricular systolic and diastolic function in septic shock Intensive Care Med 23 1997 553 560
115. J. Postel P.R. Schloerb Cardiac depression in bacteremia Ann Surg 186 1977 74 82
116. E.C. Rackow B.S. Kaufman J.L. Falk Hemodynamic response to fluid repletion in patients with septic shock: Evidence for early depression of cardiac performance Circ Shock 22 1987 11 22
117. R.F. Raper W.J. Sibbald A.A. Driedger Relative myocardial depression in normotensive sepsis J Crit Care 4 1989 9 18
118. J.M. Reilly R.E. Cunnion C. Burch-Whitman A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock Chest 95 1989 1072 1080
119. C. Reithmann S. Hallstrom G. Pilz Desensitization of rat cardiomyocyte adenylyl cyclase stimulation by plasma of noradrenaline-treated patients with septic shock Circ Shock 41 1993 48 59
120. A. Rhodes F.J. Lamb R. Malagon A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis or septic shock Crit Care Med 27 1999 2361 2366
121. A.B. Roberts Y. Vodovotz N.S. Roche Role of nitric oxide in antagonistic effects of transforming growth factor-beta and interleukin-1 beta on the beating rate of cultured cardiac myocytes Mol Endocrinol 6 1992 1921 1930
122. J. Ross Acute displacement of the diastolic pressure volume curve of the left ventricle: role of the pericardium and the right ventricle Circulation 59 1979 32 37
123. G.J. Rozanski R.C. Witt IL-1 inhibits beta-adrenergic control of cardiac calcium current: Role of L-arginine/nitric oxide pathway Am J Physiol 267 1994 H1753 H1758
124. D.D. Santis P. Phillips M.A. Spath Delayed appearance of a circulating myocardial depressant factor in burn patients Ann Emerg Med 10 1981 22 24
125. D.B. Sawyer W.S. Colucci Nitric oxide in the failing myocardium Cardiol Clin North Am 16 1998 657 664
126. A.J. Schneider G.J.J. Teule A.B.J. Groenveld Biventricular performance during volume loading in patients with early septic shock, with emphasis on the right ventricle: A combined hemodynamic and radionuclide study Am Heart J 116 1988 103 112
127. W. Schuette C. Burch P. Roach Closed loop television tracking of beating heart cells in vitro Cytometry 8 1987 101 103
128. 2+-independent nitric oxide synthase in the myocardium Br J Pharmacol 105 1992 575 580
129. E. Schupp A. Kumar E. Bunnell The cardiovascular response to incremental doses of dobutamine in septic shock: Prediction of survival Crit Care Med 22 1994 A109 Abstract
130. P. Seckinger E. Vey G. Turcatti Tumor necrosis factor inhibitor: Purification, NH2-terminal amino acid sequence and evidence for anti-inflammatory and immunomodulatory activities Eur J Immunol 20 1990 1167 1174
131. T. Shindo U. Ikeda F. Ohkawa Nitric oxide synthesis in rat cardiac myocytes and fibroblasts Life Sci 55 1994 1101 1108
132. W.C. Shoemaker Cardiorespiratory patterns in complicated and uncomplicated septic shock Ann Surg 174 1971 119 125
133. W.J. Sibbald N.A.M. Paterson R.L. Holliday Pulmonary hypertension in sepsis: Measurement by the pulmonary artery diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors Chest 73 1978 583 591
134. J.A. Smith M.W. Radomski R. Schulz Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase Br J Pharmacol 108 1993 1107 1110
135. P.A. Sobotka J. McMannis R.I. Fisher Effects of interleukin-2 on cardiac function in the isolated rat heart J Clin Invest 86 1990 845 850
136. R.T. Solis S.E. Downing Effects of E. coli endotoxemia on ventricular performance Am J Physiol 211 1966 307 313
137. M.A. Solomon R. Correa H.R. Alexander Myocardial energy metabolism and morphology in a canine model of sepsis Am J Physiol 266 1994 H757 H768
138. M. Sonnenblick A. Rosin Cardiotoxicity of interferon: A review of 44 cases Chest 99 1991 557 561
139. T.J. Stahl P.B. Alden F.B. Cerra Sepsis induced diastolic dysfunction in chronic canine peritonitis Am J Physiol 258 1990 H625 H633
140. J.R. Stratton J.A. Werner M.C. Jackson Bacteremia and the heart Am J Med 73 1982 851 858
141. A.F. Suffredini R.E. Fromm M.M. Parker The cardiovascular response of normal humans to the administration of endotoxin N Engl J Med 321 1989 280 287
142. M. Tsujino Y. Hirata T. Imai Induction of nitric oxide synthetase gene by interleukin-1 beta in cultured rat cardiocytes Circulation 90 1994 375 383
143. V.N. Udhoji M.H. Weil Hemodynamic and metabolic studies on shock associated with bacteremia Ann Intern Med 62 1965 966 978
144. D. Ungureanu-Longrois J.L. Balligand I. Okada Contractile responsiveness of ventricular myocytes to Isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture Circ Res 77 1995 486 493
145. B. Vallet C. Chopin S.E. Curtis Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: A prospective, multicenter study Crit Care Med 21 1993 1868 1875
146. J.L. Vincent J. Bakker G. Marecaux Administration of anti-TNF antibody improves left ventricular function in septic shock patients: Results of a pilot study Chest 101 1992 810 815
147. J.L. Vincent C. Reuse N. Frank Right ventricular dysfunction in septic shock: Assessment by measurements of right ventricular ejection fraction using the thermodilution technique Acta Anaesthesiol Scand 33 1989 34 38
148. J.L. Vincent M. Thirion S. Brimioulle Thermodilution measurement of right ventricular ejection fraction with a modified pulmonary artery catheter Intensive Care Med 12 1986 33 38
149. G.J. Vlahakes K. Turley J.I. Hoffman The pathophysiology of failure in right ventricular hypertension: Hemodynamic and biochemical correlates Circulation 63 1981 87 95
150. A. Waage T. Espevik Interleukin-1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice J Exp Med 167 1988 1987 1992
151. G.M. Wahler S.J. Dollinger Nitric oxide donor SIN-1 inhibits mammalian cardiac calcium current through cGMP-dependent protein kinase Am J Physiol 268 1995 C45 C54
152. B.A. Waisbren Bacteremia due to gram-negative bacilli other than the Salmonella: A clinical and therapeutic study Arch Intern Med 88 1951 467
153. G. Wakabayashi J.A. Gelfand J.F. Burke A specific receptor antagonist for interleukin-1 prevents Escherichia coli -induced shock in rabbits FASEB J 5 1991 338 343
154. G. Wakabayashi J.A. Gelfand W.K. Jung Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli J Clin Invest 87 1991 1925 1935
155. K.R. Walley P.C. Hebert Y. Wakai Decrease in left ventricular contractility after tumor necrosis factor-alpha infusion in dogs J Appl Physiol 76 1994 1060 1067
156. S.L. Wangensteen W.T. Geissenger W.L. Lovett Relationship between splanchnic blood flow and a myocardial depressant factor in endotoxin shock Surgery 69 1971 410 418
157. M.H. Weil L.D. MacLean M.D. Visscher Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms J Clin Invest 35 1956 1191 1198
158. M.H. Weil H. Nishijima Cardiac output in bacterial shock Am J Med 64 1978 920 922
159. M.H. Weil H. Shubin M. Biddle Shock caused by gram negative microorganisms Ann Intern Med 60 1964 384 400
160. J.R. Weinberg P. Boyle A. Meager Lipopolysaccharide, tumor necrosis factor and interleukin-1 interact to cause hypotension J Lab Clin Med 120 1992 205 211
161. R.D. Weisel L. Vito R.C. Dennis Myocardial depression during sepsis Am J Surg 133 1977 512 521
162. D. Weisensee J. Bereiter-Hahn I. Low-Friedrich Effects of cytokines on the contractility of cultured cardiac myocytes Int J Immunopharmacol 15 1993 581 587
163. C.J. Wiggers Myocardial depression in shock. A survey of cardiodynamic studies Am Heart J 33 1947 633 650
164. J.B. Wiles F.B. Cerra J.H. Siegel The systemic septic response: Does the organism matter? Crit Care Med 8 1980 55 60
165. R.F. Wilson E. Ackerman Hemodynamic measurements in septic shock Arch Surg 91 1965 121 129
166. R.F. Wilson W.J. Sibbald J.L. Jaanimagi Hemodynamic effects of dopamine in critically ill septic patients J Surg Res 20 1976 163 172
167. E.J. Winslow H.S. Loeb S.H. Rahimtoola Hemodynamic studies and results of therapy in 50 patients with bacteremic shock Am J Med 54 1973 421 432
168. T. Yokoyama L. Vaca R.D. Rossen Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart J Clin Invest 92 1993 2303 2312
169. E.J. Zeigler C.J. Fisher Jr C.L. Sprung Treatment of gram negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin N Engl J Med 324 1991 429 436